ArticleThe Lancet regional health. Europe2026

Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis (BeNeBio study): An International, Pragmatic, Multicentre, Randomised, Controlled, Non-Inferiority Trial.

Juul M P A van den Reek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.